Importance of Risk Assessment in Timing of Invasive Coronary Evaluation and Treatment of Patients With Non–ST‐Segment–Elevation Acute Coronary Syndrome: Insights From the VERDICT Trial

Importance of Risk Assessment in Timing of Invasive Coronary Evaluation and Treatment of Patients With Non–ST‐Segment–Elevation Acute Coronary Syndrome: Insights From the VERDICT Trial

Background The optimal timing of invasive examination and treatment of high‐risk patients with non–ST‐segment–elevation acute coronary syndrome has not been established. We investigated the efficacy of early invasive coronary angiography compared with standard‐care invasive coronary angiography on t...

Full description

Bibliographic Details
Main Authors: Jawad H. Butt, Klaus F. Kofoed, Henning Kelbæk, Peter R. Hansen, Christian Torp‐Pedersen, Dan Høfsten, Lene Holmvang, Frants Pedersen, Lia E. Bang, Per E. Sigvardsen, Peter Clemmensen, Jesper J. Linde, Merete Heitmann, Jens Dahlgaard Hove, Jawdat Abdulla, Gunnar Gislason, Thomas Engstrøm, Lars Køber
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute coronary syndrome
GRACE score
heart failure
invasive coronary angiography
mortality
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.022333

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.022333

Similar Items